Observational Research On Urban Public Awareness of Ayurveda as an Adjuvant Therapy During COVID-19
Life Sciences- Ayurveda
DOI:
https://doi.org/10.22376/ijlpr.2023.13.6.L297-L393Keywords:
COVID-19, Ayurveda, Adjuvant therapy, Epidemic disease, Immunity.Abstract
Ayurveda labels COVID-19 as Janapadodhwamsa Vikara (epidemic disease). Charaka Samhita: Vimana Sthana Chapter 3discusses epidemics; even though there is dissimilarity in the physical constitution of human beings; still there are such factorsthat are common to all individuals, and vitiation of these factors lead to the simultaneous manifestation of diseases having thesame set of symptoms leading to the destruction of countries. All citizens share air, water, location, and seasons. The subjectswere drawn from the general population who had tested positive for COVID-19. An accurate and comprehensive questionnairewas used to conduct the online survey. All of the responses were correctly completed. All information was gathered from theonline survey and properly analysed. This study included 250 COVID-19-positive participants. A questionnaire and verbaldialogue assessed COVID-19 ayurvedic adjuvant therapy utilization. 89.6% had COVID-19. 65.6% of patients have RTPCR toconfirm COVID-19. 81.2% of COVID-19 patients initially used allopathic medication, with 59.6% reporting negative effects. Afterthat, 87.2% received ayurvedic COVID-19 medicine. 96.4% of COVID-19 patients had a fever, cold, cough, and weakness.Mahasudarshana Kadha (71.2%), Samshavani Vati (66.4%), and Sitopaladi Churna (51.2%) were the top three COVID-19 medicines.Most nations treat COVID-19 with antiviral combinations for other viral infections. SARS-COV-2 antivirals may not workclinically. Ayurveda treats sickness via mind-body-physiology. Ayurvedic medicine boosts immunity and fights viruses. Ayurvedaadjuvant therapy helped COVID-19 patients. Ayurveda can treat COVID-19 symptoms without side effects.
References
Gautam S, Gautam A, Chhetri S, Bhattarai U. Immunity against COVID-19: potential role of Ayush Kwath. J Ayurveda Integr Med. 2022;13(1):100350. doi: 10.1016/j.jaim.2020.08.003, PMID 32837101.
Khanna K, Kohli SK, Kaur R, Bhardwaj A, Bhardwaj V, Ohri P, et al. Herbal immune-boosters: substantial warriors of pandemic Covid-19 battle. Phytomedicine. 2021 May;85:153361. doi: 10.1016/j.phymed.2020.153361, PMID 33485605.
COVID-19: protecting people and societies [internet] [cited Dec 13 2022]. Available from: https://www.oecd.org/coronavirus/policy-responses/covid-19-protecting-people-and-societies-e5c9de1a/.
ayurved-guidlines.pdf [internet] [cited Dec 13 2022]. Available from: https://www.ayush.gov.in/docs/ayurved-guidlines.pdf.
Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report. J Med Case Rep. 2021 Feb 24;15(1):95. doi: 10.1186/s13256-020-02624-1, PMID 33627186.
Borse S, Joshi M, Saggam A, Bhat V, Walia S, Marathe A, et al. Ayurveda botanicals in COVID-19 management: an in silico multi-target approach. PLOS ONE. 2021 Jun 11;16(6):e0248479. doi: 10.1371/journal.pone.0248479, PMID 34115763.
Yousefifard M, Zali A, Mohamed Ali K, Madani Neishaboori A, Zarghi A, Hosseini M, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med. 2020 Apr 6;8(1):e45. PMID 32309809.
Agrawal S, Pathak E, Mishra R, Mishra V, Parveen A, Mishra SK, et al. Computational exploration of the dual role of the phytochemical fortunellin: antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host. Comput Biol Med. 2022 Oct; 149:106049. doi: 10.1016/j.compbiomed.2022.106049, PMID 36103744.
Singh R, Goel S, Bourgeade P, Aleya L, Tewari D. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environ Sci Pollut Res Int. 2021;28(40):55925-51. doi: 10.1007/s11356-021-16280-5, PMID 34491498.
Patgiri B, Umretia BL, Vaishnav PU, Prajapati PK, Shukla VJ, Ravishankar B. Anti-inflammatory activity of Guduchi Ghana (aqueous extract of Tinospora cordifolia Miers.). Ayu. 2014;35(1):108-10. doi: 10.4103/0974-8520.141958, PMID 25364210.
Kaur G, Gupta V, Bansal P. Innate antioxidant activity of some traditional formulations. J Adv Pharm Technol Res. 2017;8(1):39-42. doi: 10.4103/2231-4040.197393, PMID 28217554.
Padhar BC, Dave AR, Goyal M. Clinical study of arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial. Ayu. 2019;40(3):171-8. doi: 10.4103/ayu.AYU_79_19, PMID 33281394.
Alam M, Dasan KKS, Thomas S, Suganthan J. Anti – inflammatory potential of balarishta and DHANVANTARA gutika in albino rats. Anc Sci Life. 1998;17(4):305-12. PMID 22556860.
Raju SN. To Study the Effect of Kutaja Ghana in Atisar Vegavastha (acute diarrhea); 2016 Apr 3. International Journal of Ayurveda and Pharma Research [cited Dec 13 2022]. Available from: https://ijapr.in/index.php/ijapr/article/view/315.
Sirjana Shrestha, Shankar Gautam, Sabbu Thasineku, Jitendra Shrestha, D.L. Bharkher, Binod Kumar Singh. The Effectiveness of Taalishadi Churna Compared with Sitopaladi Churna in the Management of Kasa. IJRAPS:463-70. doi: 10.47070/ijraps.v4i12.99.
Weerakoon WASS, Perera PK, Gunasekera D, Suresh TS. Evaluation of the in vitro and in vivo antioxidant potentials of Sudarshana Powder. Evid Based Complement Alternat Med. 2018 Apr 10;2018:6743862. doi: 10.1155/2018/6743862, PMID 29849719.
Kaur P, Gupta RC, Dey A, Malik T, Pandey DK. Validation and quantification of major biomarkers in ’Mahasudarshan Churna’- an ayurvedic polyherbal formulation through high-performance thin-layer chromatography. BMC Complement Med Ther. 2020 Jun 11;20(1):184. doi: 10.1186/s12906-020-02970-z, PMID 32527318.
Kashayam VP. Uses, price, dosage, side effects, substitute, buy online [internet]. myUpchar [cited Dec 13 2022]. Available from: https://www.myupchar.com/en/medicine/patoladi-kashayam-patolakaturohinyadi-kashayam-200-ml-p36766823.
Paneliya AM, Patgiri B, Galib R, Prajapati PK. Efficacy of Vasa Avaleha and its granules on Tamaka Shwasa (bronchial asthma): open-label randomized clinical study. Ayu. 2015;36(3):271-7. doi: 10.4103/0974-8520.182760, PMID 27313413.
Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Biomed. 2013 Mar;3(3):244-52. doi: 10.1016/S2221-1691(13)60059-3, PMID 23620847.
Ajanal M, Nayak S, Prasad BS, Kadam A. Adverse drug reaction and concepts of drug safety in Ayurveda: an overview. J Young Pharm. 2013 Dec;5(4):116-20. doi: 10.1016/j.jyp.2013.10.001. PMID 24563588, PMCID PMC3930110.
Thatte U, Bhalerao S. Pharmacovigilance of ayurvedic medicines in India. Indian J Pharmacol. 2008 Feb;40;Suppl 1:S10-2. PMID 21369405, PMCID PMC3038521.
Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report. J Med Case Rep. 2021;15(1):95. doi: 10.1186/s13256-020-02624-1, PMID 33627186.
Mahaboob Ali AA, Bugarcic A, Naumovski N, Ghildyal R. Ayurvedic formulations: potential COVID-19 therapeutics? Phytomed Plus. 2022 Aug;2(3):100286. doi: 10.1016/j.phyplu.2022.100286. PMID 35474908, PMCID PMC9020642.
Girija PLT, Sivan N. Ayurvedic treatment of COVID-19: A case report. J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100329. doi: 10.1016/j.jaim.2020.06.001. PMID 32680602, PMCID PMC7303645.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Shumaila Riyaz Mirza, Dr. Gaurav Sawarkar, Dr. Punam Sawarkar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
